Global & Public Health (all articles)
Global surveillance, research, and collaboration needed to improve understanding and management of long COVID.
12 Nov, 2021 | 10:32h | UTCRelated:
Update to post-acute sequelae of SARS-CoV-2 infection: Caring for the ‘long-haulers’.
Systematic Review: Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection.
WHO Consensus: A clinical case definition of post COVID-19 condition (Long Covid).
Characterizing long COVID: a living systematic review.
Long Covid – The illness narratives.
New guidelines to help doctors manage long COVID patients published.
M-A: More than 50 long-term effects of COVID-19. (several articles on the subject)
Boosting immunity to COVID-19 vaccines – “New studies highlight the immunological benefits of COVID-19 vaccine boosters, but questions remain over how to best make use of a limited global supply”.
12 Nov, 2021 | 10:37h | UTCBoosting immunity to COVID-19 vaccines – Nature Medicine
Map: The world according to covid vaccine coverage.
12 Nov, 2021 | 10:34h | UTCThe world according to covid vaccine coverage – The BMJ
Commentary on Twitter
A year since the first covid vaccines were announced, rollouts are under way all over the world—to differing degrees.
This map shows the percentage of national population to have received two doses of covid vaccinehttps://t.co/rIU3qeWXIK @munkeatlooi pic.twitter.com/zZHr1XXBe8
— The BMJ (@bmj_latest) November 11, 2021
WHO, CDC | Global progress against measles threatened amidst COVID-19 pandemic.
12 Nov, 2021 | 10:27h | UTCNews Release: Global progress against measles threatened amidst COVID-19 pandemic – World Health Organization
Commentary on Twitter (thread – click for more)
While reported #measles cases have fallen compared to previous years, progress toward measles elimination continues to decline and the risk of outbreaks is mounting, according to a 🆕 report from @CDCgov & WHO.
👉 https://t.co/EjRVRexcGd pic.twitter.com/KnBU5RZn5i
— World Health Organization (WHO) (@WHO) November 10, 2021
IDSA Guidelines on Infection Prevention for Healthcare Personnel Caring for Patients with Suspected or Known COVID-19.
11 Nov, 2021 | 09:01h | UTC
Commentary on Twitter
New recommendation on the use of eye protection as well as revised recommendations and literature on the use of PPE now available in IDSA’s COVID-19 Infection Prevention Guideline: https://t.co/MiACvSoG92#COVID19Guidelines pic.twitter.com/Zp7s0Ely9J
— IDSA (@IDSAInfo) November 5, 2021
COVID antiviral pills: what scientists still want to know – “Drugs like Molnupiravir and Paxlovid could change the course of the pandemic if clinical trial results hold up in the real world”.
11 Nov, 2021 | 08:59h | UTCCOVID antiviral pills: what scientists still want to know – Nature
Related:
The U.K. approves Merck’s COVID-19 antiviral pill, calling it a world first.
Merck to allow other nations to produce new COVID-19 antiviral.
Video: Merck’s Covid pill could transform treatment. Here’s how it works.
How antiviral pill Molnupiravir shot ahead in the COVID drug hunt.
What we know — and don’t know — about Merck’s new Covid-19 pill.
Merck’s Covid-19 pill is great news but may not be a game-changer.
Video | A Pill For COVID? A Doctor Explains Molnupiravir.
Perspective | COVID’s endgame: Scientists have a clue about where SARS-CoV-2 is headed.
11 Nov, 2021 | 08:55h | UTCCOVID’s endgame: Scientists have a clue about where SARS-CoV-2 is headed – NPR
Consensus Statement: Advancing the global public health agenda for non-alcoholic fatty liver disease.
11 Nov, 2021 | 08:48h | UTCRelated:
Non-alcoholic fatty liver disease: A patient guideline.
State of the art review: Management of non-alcoholic fatty liver disease
Review: Dietary carbohydrates and fats in nonalcoholic fatty liver disease.
Commentary on Twitter
A Consensus Statement published in @NatRevGastroHep discusses recommendations for tackling the burden of non-alcoholic fatty liver disease. https://t.co/eX7Ht53DOB pic.twitter.com/lHKsfQmSj3
— Nature Portfolio (@NaturePortfolio) November 6, 2021
RCT: Universal screening in high schools can help identify and initiate treatment for depression in adolescents.
11 Nov, 2021 | 08:35h | UTCNews release: School-based screening increases identification of, treatment for depression – Penn State
Commentaries:
Commentaries on Twitter
In a randomized clinical trial including 12,909 students at 14 Pennsylvania public high schools, adolescents randomized to receive a depression screen and identified with symptoms had 2.1 times higher odds of initiating depression treatment. https://t.co/b0l5ShCiHf pic.twitter.com/XptJDrH0Ne
— JAMA Network Open (@JAMANetworkOpen) November 8, 2021
RCT: Pfizer vaccine shows 90.7% efficacy for preventing Covid-19 in children 5 to 11 years of age.
10 Nov, 2021 | 07:24h | UTC
Commentary on Twitter
In this multi-phase trial, two 10-μg doses of the BNT162b2 vaccine administered 21 days apart were safe, immunogenic, and 90.7% effective against #COVID19 in 5-to-11-year-old children. #Covid19vaccine https://t.co/kuj2eI4YCE pic.twitter.com/BWEkYxn8a0
— NEJM (@NEJM) November 9, 2021
How an outbreak became a pandemic: a chronological analysis of crucial junctures and international obligations in the early months of the COVID-19 pandemic.
10 Nov, 2021 | 07:22h | UTC
Commentary on Twitter
NEW—How an outbreak became a pandemic: an analysis of the early months of #COVID19 by @TheIndPanel.
Authors point to reform & offer a framework for robust future #pandemic preparedness & response. https://t.co/MlW6zXj2Dn @sudhvir pic.twitter.com/rgHu1QggNQ
— The Lancet (@TheLancet) November 9, 2021
French health authority advises against Moderna Covid-19 vaccine for under 30s.
10 Nov, 2021 | 07:18h | UTCFrench Health Authority Advises Against Moderna COVID-19 Vaccine for Under 30s – Reuters
See also: France advises against Moderna for under-30s over rare heart risk – Associated Press
Related: Sweden, Denmark pause Moderna COVID-19 vaccine for younger age groups.
Commentary on Twitter
France's public health authority has recommended people under 30 be given Pfizer's Comirnaty COVID-19 vaccine when available instead of Moderna Inc's Spikevax jab, which carried comparatively higher risks of heart-related problems. https://t.co/4gPTXzEsw0
— Reuters Health (@Reuters_Health) November 9, 2021
How protein-based COVID vaccines could change the pandemic.
9 Nov, 2021 | 01:41h | UTCHow protein-based COVID vaccines could change the pandemic – Nature
We can be confident there have been far more than 5 million global Covid deaths – “Estimating ‘excess’ fatalities, a more robust analysis method, puts the pandemic’s grim toll between 10m and 19m people”.
9 Nov, 2021 | 01:43h | UTCWe can be confident there have been far more than 5 million global Covid deaths – The Guardian
Related:
Global Covid-19 deaths surpass five million.
Under-reporting of deaths limits our understanding of true burden of covid-19.
Study shows COVID-19 has caused the biggest decrease in life expectancy since World War II.
Just how do deaths due to COVID-19 stack up?
Exploring the gap between excess mortality and COVID-19 deaths in 67 countries.
COVID-19 has caused 6.9 million deaths globally, more than double what official reports show
Actions to transform USPSTF methods to mitigate systemic racism in clinical preventive services.
9 Nov, 2021 | 01:24h | UTCCommentary: USPSTF Proposes Strategies to Mitigate Racism in Preventive Care – HealthDay
Not all Covid waves look the same. Here’s a snapshot of the Delta surge.
9 Nov, 2021 | 01:28h | UTCNot all Covid waves look the same. Here’s a snapshot of the Delta surge – STAT
Commentary on Twitter
If you know someone on the fence about vaccination, show them this https://t.co/ndPLhpLlh4 pic.twitter.com/L6RLwHyGCi
— David Juurlink (@DavidJuurlink) November 8, 2021
Nose sprays, needle-free patches, durable immunity: towards the next generation of COVID vaccines.
9 Nov, 2021 | 01:31h | UTC
Systematic Review | Management of High-Need, High-Cost Patients.
9 Nov, 2021 | 01:20h | UTCSee also:
Related:
Systematic review of high-cost patients’ characteristics and healthcare utilization – BMJ Open
Multimorbidity: a priority for global health research – The Academy of Medical Sciences
The global burden of multiple chronic conditions: A narrative review – Preventive Medicine Reports
Redesigning Care for High-Cost, High-Risk Patients – Harvard Business Review
Multimorbidity: clinical assessment and management – NICE Guideline
Richard Smith: The challenge of high need, high cost patients – The BMJ Blogs
Better Care for People with Complex Needs – Institute for Healthcare Improvement
[Press release – not published yet] RCT: Pfizer’s novel Covid-19 oral antiviral treatment candidate reduced risk of hospitalization or death by 89% in interim analysis of phase 2/3 EPIC-HR study.
7 Nov, 2021 | 20:35h | UTCCommentaries:
Pfizer’s Good News Is the World’s Good News – Science
Experimental Pfizer pill prevents Covid hospitalizations and deaths – STAT
Pfizer reports good results against severe COVID-19 for its antiviral pill – CIDRAP
Covid: Pfizer says antiviral pill 89% effective in high-risk cases – BBC
Pfizer says COVID-19 pill cut hospital, death risk by 90% – Associated Press
Commentary on Twitter (thread – click for more)
Pfizer’s oral protease inhibitor PF-07321332 for #COVID19 Reduced Risk of Hospitalization or Death from 6.7% (41/612) to 1.0% (6/607) when starting within 5 days of symptom onset.
10 vs 0 deaths. #idtwitter https://t.co/ZAIm6Y5mAt— David Boulware, MD MPH (@boulware_dr) November 5, 2021
Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination.
7 Nov, 2021 | 20:29h | UTCRelated:
Heart-inflammation risk from Pfizer COVID vaccine is very low.
Viewpoint | Pediatric COVID-19 Vaccines: What Parents, Practitioners, and Policy Makers Need to Know.
7 Nov, 2021 | 20:31h | UTCPediatric COVID-19 Vaccines: What Parents, Practitioners, and Policy Makers Need to Know – JAMA
Viewpoint | Children and COVID-19 in schools.
7 Nov, 2021 | 20:24h | UTCChildren and COVID-19 in schools – Science
Related:
Instead of quarantine for Covid-exposed students, some schools are trying test-to-stay.
Opinion | Data from routine Covid testing can help schools stay open this year.
CDC Report: Schools without mask requirements were more likely to have Covid-19 outbreaks.
Perspective | Schools have begun mass testing for COVID-19. But hurdles and uncertainties remain.
COVID and schools: the evidence for reopening safely.
COVID studies note online learning stress, fewer cases in schools with protocols
[Not published yet] Chinese drug firm Sinovac says Covid-19 vaccine safe for children and babies as young as six months old.
7 Nov, 2021 | 20:32h | UTCRelated:
COVID-19 vaccination in pregnancy, pediatrics, immunocompromised patients, and persons with history of allergy or prior SARS-CoV-2 infection: overview of current recommendations and pre- and post-marketing evidence for vaccine efficacy and safety.
7 Nov, 2021 | 20:27h | UTC
Germany offers booster shots to everyone amid ‘very worrying’ surge in cases.
7 Nov, 2021 | 20:22h | UTCGermany offers booster shots to everyone amid ‘very worrying’ surge in cases – CNN